Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).

Loibl, Sibylle

Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33). [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Nov 2011 - 1789-95 p. digital

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1433-7339

10.1007/s00520-010-1020-9 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Breast Neoplasms--drug therapy
Cyclophosphamide--administration & dosage
Drug Administration Schedule
Epirubicin--administration & dosage
Female
Fever--prevention & control
Filgrastim
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Leukopenia--chemically induced
Middle Aged
Neutropenia--chemically induced
Paclitaxel--administration & dosage
Polyethylene Glycols
Prospective Studies
Recombinant Proteins--administration & dosage
Time Factors
Young Adult